In vitro and in vivo evaluation of a humanized anti-April antibody

Current Molecular Medicine

Volumn 13, Issue 3, 2013, Pages 464-465

  Gao, Q ^a   Li, Q ^b   Xue, Z ^c   Wu, P ^c   Yang, X ^c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Intellectual Property Bureau of Chongqing Science and Technology Commission   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

A proliferation inducing ligand; APRIL; Tumor necrosis factor (TNF); Tumorigenesis

Indexed keywords

3 (4, 5 DIMETHYL 2 THIAZOLYL) 2, 5 DIPHENYLTETRAZOLIUM BROMIDE; APRIL PROTEIN; GREEN FLUORESCENT PROTEIN; HUMANIZED ANTI APRIL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; HELPER CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MOLECULAR IMAGING; MOUSE; NEOPLASM; NONHUMAN; RAJI CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84877743996     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524011313030016     Document Type: Article

References (7)

1. Endo T, Nishio M, Enzler T, et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007; 109: 703-10.
2. Bojarska-Junak A, Hus I, Chocholska S, et al. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leuk Res 2009; 33: 1319-27.
3. Planelles L, Castillo-Gutiérrez S, Medema JP, Morales-Luque A, Merle-Béral H, Hahne M. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 2007; 92: 1284-5.
4. Kofler DM, Gawlik BB, Elter T, Gianella-Borradori A, Wendtner CM, Hallek M. Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia. Leukemia 2012; 26: 841-4.
5. Pan HF, Wang DG, Ye DQ. APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al. Arthritis Rheum 2012; 64: 2052-3.
6. Vosters JL, Roescher N, Polling EJ, Illei GG, Tak PP. The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland. Rheumatology (Oxford) 2012; 51: 1557-62.
7. Wang H, Wang K, Zhong X, et al. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol 2012; 32: 1007-11.